Global surface-ocean pCO2 and sea–air CO2 flux variability from an observation-driven ocean mixed-layer scheme

A temporally and spatially resolved estimate of the global surface-ocean CO₂ partial pressure field and the sea–air CO₂ flux is presented, obtained by fitting a simple data-driven diagnostic model of ocean mixed-layer biogeochemistry to surface-ocean CO₂ partial pressure data from the SOCAT v1.5 database. Results include seasonal, interannual, and short-term (daily) variations. In most regions, estimated seasonality is well constrained from the data, and compares well to the widely used monthly climatology by Takahashi et al. (2009). Comparison to independent data tentatively supports the slightly higher seasonal variations in our estimates in some areas. We also fitted the diagnostic model to atmospheric CO₂ data. The results of this are less robust, but in those areas where atmospheric signals are not strongly influenced by land flux variability, their seasonality is nevertheless consistent with the results based on surface-ocean data. From a comparison with an independent seasonal climatology of surface-ocean nutrient concentration, the diagnostic model is shown to capture relevant surface-ocean biogeochemical processes reasonably well. Estimated interannual variations will be presented and discussed in a companion paper

Sea-air CO2 fluxes in the Indian Ocean between 1990 and 2009

The Indian Ocean (44 S-30 N) plays an important role in the global carbon cycle, yet it remains one of the most poorly sampled ocean regions. Several approaches have been used to estimate net sea-air CO2 fluxes in this region: interpolated observations, ocean biogeochemical models, atmospheric and ocean inversions. As part of the RECCAP (REgional Carbon Cycle Assessment and Processes) project, we combine these different approaches to quantify and assess the magnitude and variability in Indian Ocean sea-air CO2 fluxes between 1990 and 2009. Using all of the models and inversions, the median annual mean sea-air CO2 uptake of −0.37 ± 0.06 PgC yr -1 is consistent with the −0.24 ± 0.12 PgC yr -1 calculated from observations. The fluxes from the southern Indian Ocean (18-44 S; -0.43 ± 0.07 PgC yr-1 are similar in magnitude to the annual uptake for the entire Indian Ocean. All models capture the observed pattern of fluxes in the Indian Ocean with the following exceptions: underestimation of upwelling fluxes in the northwestern region (off Oman and Somalia), overestimation in the northeastern region (Bay of Bengal) and underestimation of the CO2 sink in the subtropical convergence zone. These differences were mainly driven by lack of atmospheric CO2 data in atmospheric inversions, and poor simulation of monsoonal currents and freshwater discharge in ocean biogeochemical models. Overall, the models and inversions do capture the phase of the observed seasonality for the entire Indian Ocean but overestimate the magnitude. The predicted sea-air CO 2 fluxes by ocean biogeochemical models (OBGMs) respond to seasonal variability with strong phase lags with reference to climatological CO 2 flux, whereas the atmospheric inversions predicted an order of magnitude higher seasonal flux than OBGMs. The simulated interannual variability by the OBGMs is weaker than that found by atmospheric inversions. Prediction of such weak interannual variability in CO2 fluxes by atmospheric inversions was mainly caused by a lack of atmospheric data in the Indian Ocean. The OBGM models suggest a small strengthening of the sink over the period 1990-2009 of -0.01 PgC decade-1. This is inconsistent with the observations in the southwestern Indian Ocean that shows the growth rate of oceanic pCO 2 was faster than the observed atmospheric CO2 growth, a finding attributed to the trend of the Southern Annular Mode (SAM) during the 1990s

Data-based estimates of the ocean carbon sink variability – First results of the Surface Ocean pCO2 Mapping intercomparison (SOCOM)

Using measurements of the surface-ocean CO2 partial pressure (pCO2) and 14 different pCO2 mapping methods recently collated by the Surface Ocean pCO2 Mapping intercomparison (SOCOM) initiative, variations in regional and global sea–air CO2 fluxes are investigated. Though the available mapping methods use widely different approaches, we find relatively consistent estimates of regional pCO2 seasonality, in line with previous estimates. In terms of interannual variability (IAV), all mapping methods estimate the largest variations to occur in the eastern equatorial Pacific. Despite considerable spread in the detailed variations, mapping methods that fit the data more closely also tend to agree more closely with each other in regional averages. Encouragingly, this includes mapping methods belonging to complementary types – taking variability either directly from the pCO2 data or indirectly from driver data via regression. From a weighted ensemble average, we find an IAV amplitude of the global sea–air CO2 flux of 0.31 PgC yr−1 (standard deviation over 1992–2009), which is larger than simulated by biogeochemical process models. From a decadal perspective, the global ocean CO2 uptake is estimated to have gradually increased since about 2000, with little decadal change prior to that. The weighted mean net global ocean CO2 sink estimated by the SOCOM ensemble is −1.75 PgC yr−1 (1992–2009), consistent within uncertainties with estimates from ocean-interior carbon data or atmospheric oxygen trend

The ruptured Achilles tendon: operative and non-operative treatment options

The Achilles tendon is the strongest and thickest tendon in the human body. Like any other tendon in the body, however, it is susceptible to rupture. Many surgeons advocate early operative repair of the ruptured Achilles tendon, citing decreased re-rupture rates and improved functional outcome. Waiting for surgical repair for longer than one month may lead to inferior functional results postoperatively. Non-operative treatment has higher re-rupture rates as compared to surgically repaired tendons, but may be the treatment of choice in some patients. While for many years, patients were rigidly immobilized in a non-weightbearing cast for 6–8 weeks postoperatively, newer studies have shown excellent results with early weightbearing, and this is quickly becoming the standard of care amongst many physicians

An assessment of the Atlantic and Arctic sea–air CO2 fluxes, 1990–2009

© The Author(s), 2013. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Biogeosciences 10 (2013): 607-627, doi:10.5194/bg-10-607-2013.The Atlantic and Arctic Oceans are critical components of the global carbon cycle. Here we quantify the net sea–air CO2 flux, for the first time, across different methodologies for consistent time and space scales for the Atlantic and Arctic basins. We present the long-term mean, seasonal cycle, interannual variability and trends in sea–air CO2 flux for the period 1990 to 2009, and assign an uncertainty to each. We use regional cuts from global observations and modeling products, specifically a pCO2-based CO2 flux climatology, flux estimates from the inversion of oceanic and atmospheric data, and results from six ocean biogeochemical models. Additionally, we use basin-wide flux estimates from surface ocean pCO2 observations based on two distinct methodologies. Our estimate of the contemporary sea–air flux of CO2 (sum of anthropogenic and natural components) by the Atlantic between 40° S and 79° N is −0.49 ± 0.05 Pg C yr−1, and by the Arctic it is −0.12 ± 0.06 Pg C yr−1, leading to a combined sea–air flux of −0.61 ± 0.06 Pg C yr−1 for the two decades (negative reflects ocean uptake). We do find broad agreement amongst methodologies with respect to the seasonal cycle in the subtropics of both hemispheres, but not elsewhere. Agreement with respect to detailed signals of interannual variability is poor, and correlations to the North Atlantic Oscillation are weaker in the North Atlantic and Arctic than in the equatorial region and southern subtropics. Linear trends for 1995 to 2009 indicate increased uptake and generally correspond between methodologies in the North Atlantic, but there is disagreement amongst methodologies in the equatorial region and southern subtropics.U. Schuster has been supported by EU grants IP 511176-2 (CARBOOCEAN), 212196 (COCOS), and 264879 (CARBOCHANGE), and UK NERC grant NE/H017046/1 (UKOARP). G. A. McKinley and A. Fay thank NASA for support (NNX08AR68G, NNX11AF53G). P. Landsch¨utzer has been supported by EU grant 238366 (GREENCYCLESII). N. Metzl acknowledges the French national funding program LEFE/INSU. Support for N. Gruber has been provided by EU grants 264879 (CARBOCHANGE) and 283080 (GEO-CARBON) S. Doney acknowledges support from NOAA (NOAA-NA07OAR4310098). T. Takahashi is supported by NOAA (NAO80AR4320754)

Physician Attitudes towards Pharmacological Cognitive Enhancement: Safety Concerns Are Paramount

The ethical dimensions of pharmacological cognitive enhancement have been widely discussed in academic circles and the popular media, but missing from the conversation have been the perspectives of physicians - key decision makers in the adoption of new technologies into medical practice. We queried primary care physicians in major urban centers in Canada and the United States with the aim of understanding their attitudes towards cognitive enhancement. Our primary hypothesis was that physicians would be more comfortable prescribing cognitive enhancers to older patients than to young adults. Physicians were presented with a hypothetical pharmaceutical cognitive enhancer that had been approved by the regulatory authorities for use in healthy adults, and was characterized as being safe, effective, and without significant adverse side effects. Respondents overwhelmingly reported increasing comfort with prescribing cognitive enhancers as the patient age increased from 25 to 65. When asked about their comfort with prescribing extant drugs that might be considered enhancements (sildenafil, modafinil, and methylphenidate) or our hypothetical cognitive enhancer to a normal, healthy 40 year old, physicians were more comfortable prescribing sildenafil than any of the other three agents. When queried as to the reasons they answered as they did, the most prominent concerns physicians expressed were issues of safety that were not offset by the benefit afforded the individual, even in the face of explicit safety claims. Moreover, many physicians indicated that they viewed safety claims with considerable skepticism. It has become routine for safety to be raised and summarily dismissed as an issue in the debate over pharmacological cognitive enhancement; the observation that physicians were so skeptical in the face of explicit safety claims suggests that such a conclusion may be premature. Thus, physician attitudes suggest that greater weight be placed upon the balance between safety and benefit in consideration of pharmacological cognitive enhancement